Lisa Gill
Stock Analyst at J.P. Morgan
(4.51)
# 1,068
Out of 4,629 analysts
436
Total ratings
59.4%
Success rate
8.9%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Rated: Buy | $330 → $360 | $319.17 | +12.79% | 15 | Aug 3, 2026 | |
| CI The Cigna Group | Maintained: Buy | n/a | $282.49 | - | 22 | Jul 30, 2026 | |
| DGX Quest Diagnostics | Rated: Hold | $220 → $250 | $238.35 | +4.89% | 19 | Jul 28, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $466 → $516 | $407.08 | +26.76% | 29 | Jul 21, 2026 | |
| PGNY Progyny | Maintained: Hold | $26 → $27 | $28.10 | -3.91% | 4 | Jul 6, 2026 | |
| HUM Humana | Maintained: Hold | $214 → $316 | $385.00 | -17.92% | 22 | Jun 8, 2026 | |
| ELV Elevance Health | Maintained: Buy | $411 → $476 | $394.20 | +20.75% | 19 | Jun 8, 2026 | |
| CVS CVS Health | Maintained: Buy | n/a | $95.70 | - | 32 | May 27, 2026 | |
| LFST LifeStance Health Group | Maintained: Hold | $9 | $10.84 | -16.97% | 12 | May 18, 2026 | |
| MCK McKesson | Rated: Buy | $1,107 → $1,015 | $869.58 | +16.72% | 46 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $40 → $33 | $23.79 | +38.71% | 15 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $243 → $215 | $236.40 | -9.05% | 22 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $21 | $95.51 | -78.01% | 15 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 | $7.13 | -1.82% | 28 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 | $23.67 | +9.84% | 1 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $53 | $35.23 | +50.44% | 2 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $35 | $22.45 | +55.90% | 18 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.68 | - | 8 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $417 → $419 | $320.46 | +30.75% | 27 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $23 | $14.37 | +60.06% | 12 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $6 → $10 | $9.49 | +5.37% | 6 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 → $6 | $2.80 | +114.29% | 17 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $31 | $34.06 | -8.98% | 3 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $24.23 | n/a | 1 | Jun 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 → $27 | $15.53 | n/a | 9 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $110 | $80.05 | n/a | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $6 → $5 | $11.18 | n/a | 7 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $18 | $48.44 | n/a | 3 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $82 → $80 | $65.77 | n/a | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $19 | $11.55 | n/a | 2 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $257 → $379 | $413.36 | n/a | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $378 | $196.45 | n/a | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $172 | $262.13 | n/a | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $226 | $173.54 | n/a | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $88 → $83 | $88.16 | n/a | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 | $4.76 | n/a | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $3.95 | n/a | 2 | Aug 5, 2016 |
Labcorp Holdings
Aug 3, 2026
Rated: Buy
Price Target: $330 → $360
Current: $319.17
Upside: +12.79%
The Cigna Group
Jul 30, 2026
Maintained: Buy
Price Target: n/a
Current: $282.49
Upside: -
Quest Diagnostics
Jul 28, 2026
Rated: Hold
Price Target: $220 → $250
Current: $238.35
Upside: +4.89%
UnitedHealth Group
Jul 21, 2026
Maintained: Buy
Price Target: $466 → $516
Current: $407.08
Upside: +26.76%
Progyny
Jul 6, 2026
Maintained: Hold
Price Target: $26 → $27
Current: $28.10
Upside: -3.91%
Humana
Jun 8, 2026
Maintained: Hold
Price Target: $214 → $316
Current: $385.00
Upside: -17.92%
Elevance Health
Jun 8, 2026
Maintained: Buy
Price Target: $411 → $476
Current: $394.20
Upside: +20.75%
CVS Health
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $95.70
Upside: -
LifeStance Health Group
May 18, 2026
Maintained: Hold
Price Target: $9
Current: $10.84
Upside: -16.97%
McKesson
May 8, 2026
Rated: Buy
Price Target: $1,107 → $1,015
Current: $869.58
Upside: +16.72%
May 4, 2026
Rated: Buy
Price Target: $40 → $33
Current: $23.79
Upside: +38.71%
May 4, 2026
Rated: Hold
Price Target: $243 → $215
Current: $236.40
Upside: -9.05%
May 4, 2026
Downgraded: Sell
Price Target: $21
Current: $95.51
Upside: -78.01%
Mar 13, 2026
Rated: Hold
Price Target: $7
Current: $7.13
Upside: -1.82%
Mar 12, 2026
Rated: Buy
Price Target: $26
Current: $23.67
Upside: +9.84%
Mar 10, 2026
Rated: Buy
Price Target: $50 → $53
Current: $35.23
Upside: +50.44%
Mar 6, 2026
Maintained: Buy
Price Target: $33 → $35
Current: $22.45
Upside: +55.90%
Feb 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.68
Upside: -
Feb 10, 2026
Maintained: Buy
Price Target: $417 → $419
Current: $320.46
Upside: +30.75%
Dec 17, 2025
Maintained: Buy
Price Target: $20 → $23
Current: $14.37
Upside: +60.06%
Sep 18, 2025
Upgraded: Hold
Price Target: $6 → $10
Current: $9.49
Upside: +5.37%
Aug 27, 2025
Maintained: Sell
Price Target: $7 → $6
Current: $2.80
Upside: +114.29%
Aug 21, 2025
Maintained: Buy
Price Target: $30 → $31
Current: $34.06
Upside: -8.98%
Jun 6, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $24.23
Upside: n/a
May 16, 2025
Maintained: Hold
Price Target: $28 → $27
Current: $15.53
Upside: n/a
Mar 19, 2025
Maintained: Buy
Price Target: $120 → $110
Current: $80.05
Upside: n/a
Dec 17, 2024
Downgraded: Sell
Price Target: $6 → $5
Current: $11.18
Upside: n/a
Dec 17, 2024
Downgraded: Hold
Price Target: $40 → $18
Current: $48.44
Upside: n/a
Nov 12, 2024
Maintained: Hold
Price Target: $82 → $80
Current: $65.77
Upside: n/a
Aug 30, 2024
Maintained: Hold
Price Target: $18 → $19
Current: $11.55
Upside: n/a
Aug 9, 2024
Maintained: Hold
Price Target: $257 → $379
Current: $413.36
Upside: n/a
Aug 9, 2024
Maintained: Buy
Price Target: $378
Current: $196.45
Upside: n/a
Aug 9, 2024
Maintained: Buy
Price Target: $172
Current: $262.13
Upside: n/a
Aug 9, 2024
Maintained: Hold
Price Target: $226
Current: $173.54
Upside: n/a
Aug 9, 2023
Maintained: Hold
Price Target: $88 → $83
Current: $88.16
Upside: n/a
Jul 12, 2021
Downgraded: Sell
Price Target: $9
Current: $4.76
Upside: n/a
Aug 5, 2016
Maintained: Buy
Price Target: $26
Current: $3.95
Upside: n/a